江苏华兰药用新材料股份有限公司 江苏华兰药用新材料股份有限公司

Cn

2009 China Quality Association for Pharmaceuticals is held in Wuxi

Release date:2009-12-17

2009 China Quality Association for Pharmaceuticals is held in Wuxi

The 20th anniversary celebration of China Quality Association for Pharmaceuticals themed by "Quality Superior, Challenging the Future" was held on Oct 30~31 in Wuxi. International Forum for Pharmaceutical Quality Management was also successfully during this period. Vice Chairman of the NPC Standing Committee -- Mr. Shang Weiguo sent congratulatory letter and vice director of the State Food and Drug Administration -- Mr. Bian Zhenjia attended and delivered a speech. Leaders from the Drug Registration Division and Drug Regulatory Authorities of the SFDA as well as experts from World Health Organization, FDA China office and other institutions spreaded out splendid multi-angle speeches around pharmaceutical quality.

 
On the congress, chairman of China Quality Association for Pharmaceuticals -- Mr. Zhang Heyong introduced achievements obtained by organizing enterprises to constantly widen range of quality management on a basis of activities of QC team as well as implementing 6 standards including GMP and GSP. In China, now, the number of QC teams is increased by 3000 from the original 13 in 1980; number of people's to take part in announcing achievements in QC activities is increased by 5000 today from the original 50; by 2009, achievement communications had brought nearly an accumulative economic benefits of RMB100000000000. China Quality Association for Pharmaceuticals has fully played a role as bridge and link to carry out multiple activities such as appraisal of demonstrative pharmaceutical enterprises with quality credibility construction in order to improve consciousness of the enterprises on the implementation of laws and regulations and improve law enforcement credibility of the government and supervision and regulation departmentsocial and social trust of enterprises.
 
Vice director of the State Food and Drug Administration -- Mr. Bian Zhenjia emphasized that pharmaceutical safety is the root of a pharmaceutical enterprise; any pharmaceutical enterprise should always give top priority to quality control of pharmaceuticals.
 
Bian Zhenjia said, Premier Wen Jiabao pointed out in 2009 Government Work Report that he would work program on thoroughly rectifing and standardizing order in the market, on activities in relation to "Quality Safety Year" and on program on thoroughly rectifing food and drug safety throughout the country in 2009. As a responsible department for pharmaceutical safety, the SFDA has always regarded the jumping-off place of all jobs and stay dot as pharmaceutical security, taken a series of measures to strengthen supervision and control and obtained some certain achievements.
 
Bian Zhenjia also emphasized, multiple cases of chemical injuries in recent years fully proved that pharmaceutical safety was the root of a pharmaceutical enterprise, any pharmaceutical enterprise should always give top priority to quality control of pharmaceuticals. This was much more than just a slogan but the principle that pharmaceutical enterprises must follow. In the current situation, pharmaceutical enterprises should be strictly obedient with Drug Administration Law, enhance sense of social responsibility, has the courage to take responsibility of the first responsibility for pharmaceutical safety, energetically explore new management approach and development pattern, constantly increase the investment for innovative research and development, continuously strengthen competitive capacity of enterprises and live up to emphasizing credit, complying with contract and law and scientific operation to guarantee pharmaceutical safety and effectiveness in order to realize harmonious unity between self-development and social development.
 
There's no doubt that honesty and self-discipline of pharmaceutical manufacturer as well as interest and support from the society are indispensable factors for quality guarantee of pharmaceuticals. In this case, sponsor sent out "Initial Written Proposal for Quality Credibility" to domestic pharmaceutical enterprises during this congress, appealling these enterprises to build "the first line of defence" of pharmaceutical quality with honesty and self-discipline. This proposal was warmly received by many participants.